|
NIBM Update 12-19-2002 (Number 14) |
|
- Cover -
Diuretics are blood pressure champs
- Page 2 -
More study details on Provenge
- Page 3 -
Macro Market Notes & Analysis
- Page 4 -
NIBM Model Portfolio Updates
-
(GNTA, IDEV, TGEN, NABI)
- Page 4 -
News Briefs
- Titan releases bad news on CeaVac
- Alliance parcelling itself out
- Casodex turned back by FDA committee
-
Corixa's Bexxar finally gets a nod
|
 |
|
| NIBM Updates are
available only to subscribers. In each update we analyze current market trends inside and
outside the biotech market sector. We also provide updates on the companies that appear in
our monthly NIBM Newsletter. Click on the box above to become a
subscriber today! |
Subscriber direct access |
|
| |
|
|
 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
